Stockscreener 앱 받기
17.45
0.85%
-0.15
시간 외 거래:
17.40
-0.05
-0.29%
전일 마감가:
$17.60
열려 있는:
$17.23
하루 거래량:
87,154
Relative Volume:
0.89
시가총액:
$223.97M
수익:
$19.85M
순이익/손실:
$-12.75M
주가수익비율:
-12.64
EPS:
-1.38
순현금흐름:
$-21.94M
1주 성능:
-0.40%
1개월 성능:
+1.34%
6개월 성능:
+7.12%
1년 성능:
+4.18%
1일 변동 폭
$16.82
$17.57
1주일 범위
$16.82
$17.81
52주 변동 폭
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.45 | 225.90M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-02 | 개시 | Alliance Global Partners | Buy |
| 2025-02-28 | 개시 | Craig Hallum | Buy |
| 2024-07-16 | 재확인 | Maxim Group | Buy |
| 2022-12-22 | 개시 | Maxim Group | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-09-23 | 개시 | BTIG Research | Buy |
| 2016-11-28 | 개시 | Aegis Capital | Buy |
| 2016-08-17 | 개시 | Wells Fargo | Outperform |
| 2014-04-16 | 개시 | Oppenheimer | Outperform |
모두보기
Mediwound Ltd 주식(MDWD)의 최신 뉴스
MediWound (MDWD) Heavy FY 2025 Losses Test High Growth And Premium P/S Narrative - simplywall.st
MediWound Files Annual Report on Form 20-F - GlobeNewswire
MediWound Q4 2025 Earnings Call Transcript - MarketBeat
MediWound Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
MediWound (NASDAQ:MDWD) Releases Quarterly Earnings Results - MarketBeat
MediWound (MDWD) Q4 2025 Earnings Call Transcript - AOL.com
MDWD: Expanded manufacturing, clinical progress, and strong guidance despite 2025 revenue decline - TradingView
MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
MediWound: Q4 Earnings Snapshot - kens5.com
Mediwound earnings beat by $0.03, revenue fell short of estimates - Investing.com India
MDWD Maintains Revenue Forecasts Through 2028 - GuruFocus
MediWound (MDWD) Reports Lower-than-Expected Q4 Revenue - GuruFocus
MediWound: Overview of Fourth Quarter Financial Results - Bitget
MEDIWOUND ($MDWD) Releases Q4 2025 Earnings - Quiver Quantitative
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity - TipRanks
MediWound (NASDAQ: MDWD) posts 2025 loss with cash rising above $53M - Stock Titan
Insights into MediWound Q4 Earnings - Benzinga
MediWound boosts burn drug output sixfold, guides to $24–26M 2026 sales - Stock Titan
MediWound Ltd. recently announced that it has once again confirmed its financial forecast targets for the coming years. - Bitget
What to Expect from MediWound's Earnings - Benzinga
Earnings Preview: MediWound to Report Financial Results Pre-market on March 05 - 富途牛牛
Mediwound Ltd expected to post a loss of 63 cents a shareEarnings Preview - TradingView
MediWound at TD Cowen Conference: Strategic Growth and Market Expansion - Investing.com India
MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference - MarketBeat
Clal Insurance Enterprises Holdings Ltd Acquires New Position in MediWound Ltd. $MDWD - MarketBeat
MediWound at Oppenheimer Conference: Strategic Growth and Innovation By Investing.com - Investing.com Australia
MediWound (MDWD) Expected to Announce Earnings on Thursday - MarketBeat
(MDWD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MediWound (NASDAQ:MDWD) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will MediWound Ltd. stock benefit from green energy trendsEarnings Summary Report & Safe Swing Trade Setups - mfd.ru
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool - The Globe and Mail
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results - Bitget
Will MediWound Ltd. stock outperform international peersJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - mfd.ru
MediWound Ltd. (NASDAQ:MDWD) Short Interest Up 20.9% in January - MarketBeat
MediWound to Present at Upcoming Investor Conferences - Bitget
MediWound Ltd. (NASDAQ:MDWD) Receives $33.50 Consensus PT from Analysts - Defense World
How (MDWD) Movements Inform Risk Allocation Models - Stock Traders Daily
Why MediWound Ltd. stock is favored by pension funds2025 EndofYear Setup & Smart Swing Trading Techniques - mfd.ru
Will MediWound Ltd. benefit from sector rotationMarket Risk Report & Technical Confirmation Alerts - mfd.ru
VIX Spike: Should I set a stop loss on MediWound LtdJuly 2025 Snapshot & AI Optimized Trading Strategy Guides - baoquankhu1.vn
What is MediWound Ltd.’s market position2025 Momentum Check & Risk Adjusted Buy/Sell Alerts - mfd.ru
HOLD Alapkezelo Zrt. discloses 8.1% MediWound (MDWD) ownership in amended filing - Stock Titan
Rally Mode: Will MediWound Ltd stock recover after earningsBull Run & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Yelin Lapidot Holdings Management Ltd. Adjusts Stake in MediWoun - GuruFocus
Can MediWound Ltd. stock beat market expectations this quarterEarnings Beat & Weekly Watchlist for Hot Stocks - mfd.ru
Can MediWound Ltd. stock deliver consistent earnings growthWeekly Loss Report & Reliable Price Action Trade Plans - mfd.ru
Can MediWound Ltd keep up with sector leadersPortfolio Profit Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
MediWound (NASDAQ:MDWD) Share Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
Trading Systems Reacting to (MDWD) Volatility - Stock Traders Daily
Aug Spikes: Will MediWound Ltd outperform the market in YEAR2025 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
Mediwound Ltd (MDWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):